Patent Troll Defense

A patent troll (or non-practicing entity, NPE) is a company or individual that holds patents primarily to assert them for licensing fees rather than to manufacture or sell products: DEFINITION: NPEs do not practice the patents they assert; they do not make competing products; they generate revenue exclusively from licensing fees and litigation settlements; SPECTRUM OF NPEs: (a) PATENT ASSERTION ENTITIES (PAEs): companies formed specifically to acquire and assert patents; (b) FAILED STARTUPS: companies that failed to commercialize technology but retained valuable patents; (c) INDIVIDUAL INVENTORS: inventors who sold their products business but retained patents; (d) UNIVERSITIES: academic institutions with large patent portfolios; most universities license fairly, but some have adopted aggressive assertion strategies; (e) PRIVATEERING: operating companies sell/license patents to NPEs to assert against competitors (to avoid the counter-suit risk); WHY DIFFERENT FROM COMPETITOR DISPUTES: a competitor asserting patents can be counter-sued (cross-licensing leverage); a pure NPE typically has no products to countersue over; this asymmetry favors the NPE: defendant cannot retaliate; NPE has nothing to lose except attorney fees and a failed lawsuit; BUSINESS MODEL: NPE sends C&D letters to many companies; most pay small 'nuisance value' settlements ($25K–$250K) to avoid litigation costs; a fraction of recipients litigate; the NPE needs to win or settle enough to cover its costs; eBay v. MercExchange (S.Ct. 2006): NPEs cannot routinely obtain injunctive relief (no irreparable harm from non-competing entity); damages are the primary remedy; IMPACT: Unified Patents estimates NPEs file ~70% of all US patent lawsuits; costs defendants ~$29B/year in direct costs.

Effective NPE defense begins with rapid assessment and a coordinated early strategy: STEP 1 — RAPID PATENT ANALYSIS (first 30 days): obtain a copy of the asserted patent and prosecution file history; conduct claim mapping: compare each asserted claim element to your accused product; identify the best invalidity arguments (prior art, § 101, § 112); rate the overall strength of the assertion (1-10 scale for validity and infringement); STEP 2 — § 101 ALICE MOTION (for software/business method patents): if the patent claims abstract ideas implemented on a computer, file a Rule 12(b)(6) motion to dismiss for § 101 patent ineligibility; Alice/Mayo framework: does the claim recite only an abstract idea + generic implementation?; § 101 motions can resolve the case without expensive discovery; courts grant these motions frequently for software patents; fast (3–6 months) and cheap ($50K–$150K); STEP 3 — IPR PETITION ASSESSMENT: evaluate whether the patent is vulnerable to invalidity in an IPR petition; IPR requires a budget of ~$300K–$500K but provides a high invalidity rate (~60–70% of challenged claims); time bar: must file within 1 year of service of complaint (§ 315(b)); filing IPR petition + moving to stay the district court case is often the most cost-effective defense; STEP 4 — EARLY CASE CONFERENCE: many courts require an early case conference and set a schedule before major costs accumulate; use the scheduling order to push for an early Markman hearing (may resolve non-infringement via claim construction); STEP 5 — INTER-COMPANY COALITION: if the NPE has sued multiple companies on the same patent, consider coordinating with co-defendants to share invalidity research and IPR petition costs.

The license vs. litigate decision depends on several quantitative and qualitative factors: QUANTITATIVE FACTORS — EXPECTED VALUE ANALYSIS: compute the 'expected value' of fighting: P(win) × defense cost + P(loss) × (damages + defense cost); compare to the licensing fee offered; if the licensing fee < expected value of fighting, license; example: NPE demands $500K; your analysis shows 80% chance of winning, $2M total litigation cost, and $5M damages exposure if you lose; expected cost of fighting = (0.8 × $2M) + (0.2 × ($5M + $2M)) = $1.6M + $1.4M = $3M > $500K; license; QUALITATIVE FACTORS: (a) PRECEDENT RISK: licensing creates a record that others will cite; expect more NPEs if you license; operating companies pay $X → NPE's database records your 'willingness to pay'; (b) MESSAGE: litigating aggressively deters future assertions (reputation as a 'hard target'); (c) PATENT QUALITY: if the patent is clearly invalid or non-infringed, fighting may be more valuable as deterrence; (d) RESOURCES: do you have the management bandwidth and legal budget to fight a 2-4 year case?; (e) PUBLICITY: patent troll cases generate press; a high-profile win may be worth the cost; VALUATION TOOLS: check PACER for the NPE's litigation history — how many cases filed, settled, lost?; review comparable licenses (if any are public); assess royalty rate using Georgia-Pacific factors; typical NPE licenses range from $25K–$500K for smaller assertions to $5M+ for large-scale assertions; OCTANE FITNESS RISK: if the patent is clearly invalid and the NPE persists, an § 285 exceptional case fee award is possible; rare but powerful deterrent for frivolous assertions.

IPR is the most powerful invalidity tool against NPE patents and has fundamentally changed the NPE business model: WHY IPR IS EFFECTIVE AGAINST NPEs: PTAB invalidation rate: ~60–70% of challenged claims are cancelled or amended in final written decisions; cost: $300K–$500K vs. $3M–$15M for district court litigation; time: FWD within 12 months of institution; stay of district court proceedings is often granted post-institution; FILING REQUIREMENTS: petition must be filed within 1 year of service of a complaint alleging infringement (§ 315(b)); the petition must identify: (a) all real parties in interest (RPIs); (b) specific prior art references; (c) detailed claim charts showing how prior art anticipates or renders obvious each challenged claim; INSTITUTION STANDARD: PTAB institutes IPR if there is a 'reasonable likelihood that the petitioner would prevail with respect to at least one of the challenged claims' (§ 314(a)); ~60–70% of petitions are instituted; PTAB DISCRETIONARY DENIAL (FINTIV): PTAB may deny institution if: (a) there is significant investment in the district court case; (b) trial date is imminent; NHK-Fintiv analysis; file IPR early to avoid Fintiv denial; ESTOPPEL RISK: after FWD, petitioner and RPIs are estopped from raising grounds raised OR REASONABLY COULD HAVE BEEN RAISED in the IPR in district court; do not use IPR if you need to preserve all invalidity arguments for district court; COALITION IPR: in NPE mass assertion campaigns (same patent, many defendants), forming a coalition to fund a single IPR petition divides the cost; third-party funder arrangements are also used for IPR costs; OUTCOME: if IPR cancels all asserted claims, the district court case is moot; if IPR cancels some claims, the damages calculation changes dramatically.

Beyond case-specific strategies, companies can use broader tools to combat patent troll activity: DEMAND LETTER LEGISLATION: many states have enacted bad faith demand letter laws (Vermont 2013 was first); prohibit demand letters that lack good-faith infringement analysis, misrepresent patent validity, or omit required information (specific claims, accused products); FTC § 5 enforcement against deceptive NPE demand letters; PATENT MISJOINDER REFORM (AIA): AIA amended § 299 to prevent NPEs from joining multiple unrelated defendants in a single lawsuit (the old 'spray and pray' tactic); each defendant must now be sued separately or in separate cases if their infringement does not arise from the same transaction or occurrence; UNIFIED PATENTS: industry consortium that conducts IPR challenges on behalf of members against the most frequently asserted NPE patents; members pay annual fees; Unified Patents files IPRs proactively on the most problematic NPE patents before they reach litigation; RPX CORPORATION: defensive patent aggregator that acquires patents that could be used against members and provides RPX licenses; defensive patent aggregation as insurance; ALICE/§ 101 LAW: continued § 101 litigation against software and business method patents invalidated many NPE patents post-Alice; many NPEs shifted away from broad software claims; § 285 FEE SHIFTING (OCTANE FITNESS): Octane Fitness v. Icon Health (S.Ct. 2014) lowered the threshold for exceptional case fee awards; courts can award defendant's attorney fees when the NPE's case is objectively weak; deters frivolous assertions but is still rare in practice; INTER-COMPANY SHARING: LOT Network and other defensive license-sharing organizations allow member companies to share licenses across patent portfolios acquired by NPEs; when a member transfers a patent to an NPE, other members get a license automatically.